LONDON--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease has launched a new electronic storybook (e-book) to support children living with rare kidney disease, atypical Haemolytic Uraemic Syndrome ...
Novartis rolls out encouraging phase 2 data in rare kidney diseases with little competition in sight
Novartis rolled out results from two phase 2 clinical trials for investigational kidney disease medicine iptacopan that showed stabilization of kidney function in one and the reduction of a key marker ...
Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact cause is unknown. Possible C3G causes include genetic mutations, autoantibodies, and certain autoimmune conditions.
Most people are familiar with the immune system and its role in protecting against diseases and infection. But what about the complement system? The complement system is a foundational part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results